Literature DB >> 16682712

Current management of the complications of portal hypertension: variceal bleeding and ascites.

Nina Dib1, Frédéric Oberti, Paul Calès.   

Abstract

Portal hypertension is one of the main consequences of cirrhosis. It results from a combination of increased intrahepatic vascular resistance and increased blood flow through the portal venous system. The condition leads to the formation of portosystemic collateral veins. Esophagogastric varices have the greatest clinical impact, with a risk of bleeding as high as 30% within 2 years of medium or large varices developing. Ascites, another important complication of advanced cirrhosis and severe portal hypertension, is sometimes refractory to treatment and is complicated by spontaneous bacterial peritonitis and hepatorenal syndrome. We describe the pathophysiology of portal hypertension and the current management of its complications, with emphasis on the prophylaxis and treatment of variceal bleeding and ascites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682712      PMCID: PMC1455434          DOI: 10.1503/cmaj.051700

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  150 in total

Review 1.  Hemodynamic evaluation of the patient with portal hypertension.

Authors:  J Bosch; R Mastai; D Kravetz; M Navasa; J Rodés
Journal:  Semin Liver Dis       Date:  1986-11       Impact factor: 6.115

2.  Localization of increased hepatic vascular resistance in liver cirrhosis.

Authors:  Y Shibayama; K Nakata
Journal:  Hepatology       Date:  1985 Jul-Aug       Impact factor: 17.425

3.  Short-term effects of propranolol on portal venous pressure.

Authors:  G Garcia-Tsao; N D Grace; R J Groszmann; H O Conn; M M Bermann; M J Patrick; S S Morse; J L Alberts
Journal:  Hepatology       Date:  1986 Jan-Feb       Impact factor: 17.425

4.  Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis.

Authors:  J Bosch; R Masti; D Kravetz; J Bruix; J Gaya; J Rigau; J Rodes
Journal:  Hepatology       Date:  1984 Nov-Dec       Impact factor: 17.425

5.  Measurement of azygos venous blood flow by a continuous thermal dilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis.

Authors:  J Bosch; R J Groszmann
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

6.  Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol.

Authors:  P Calès; A Braillon; M I Jirón; D Lebrec
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

7.  Portal pressure, presence of gastroesophageal varices and variceal bleeding.

Authors:  G Garcia-Tsao; R J Groszmann; R L Fisher; H O Conn; C E Atterbury; M Glickman
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

8.  Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage.

Authors:  G Bleichner; R Boulanger; P Squara; J P Sollet; A Parent
Journal:  Br J Surg       Date:  1986-09       Impact factor: 6.939

9.  Assessment of short-term prognosis after variceal bleeding in patients with alcoholic cirrhosis by early measurement of portohepatic gradient.

Authors:  J P Vinel; J Cassigneul; M Levade; J J Voigt; J P Pascal
Journal:  Hepatology       Date:  1986 Jan-Feb       Impact factor: 17.425

10.  Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial.

Authors:  D Westaby; B R Macdougall; R Williams
Journal:  Hepatology       Date:  1985 Sep-Oct       Impact factor: 17.425

View more
  17 in total

1.  [6 years of the International Union of Societies of Immunology. Presidential report (Brighton 1974)].

Authors:  B Cinader
Journal:  Medicina (B Aires)       Date:  1975 Jul-Aug       Impact factor: 0.653

2.  Clinical research on navel application of Shehuang Paste combined with Chinese herbal colon dialysis in treatment of refractory cirrhotic ascites complicated with azotemia.

Authors:  Guang-Dong Tong; Da-Qiao Zhou; Jing-Song He; Lai Zhang; Zhi-Fei Chen; Chun-Ling Xiao; Li-Sheng Peng
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

3.  Esophageal varices and portal hypertensive gastropathy associated with hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Takehiko Mori; Yoshinobu Aisa; Tomoharu Yajima; Takayuki Shimizu; Jun Kato; Tomonori Nakazato; Toshifumi Hibi; Yasuo Ikeda; Shinichiro Okamoto
Journal:  Int J Hematol       Date:  2008-02-07       Impact factor: 2.490

4.  Ascites in patients with cirrhosis.

Authors:  Giulia-Anna Perri
Journal:  Can Fam Physician       Date:  2013-12       Impact factor: 3.275

5.  PPIs are not associated with a lower incidence of portal-hypertension-related bleeding in cirrhosis.

Authors:  Mauricio Garcia-Saenz-de-Sicilia; Francisco Sanchez-Avila; Norberto-C Chavez-Tapia; Gustavo Lopez-Arce; Sandra Garcia-Osogobio; Roberto Ruiz-Cordero; Felix-I Tellez-Avila
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

6.  Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients.

Authors:  Walkíria Wingester Vilas-Boas; Antônio Ribeiro-Oliveira; Renata da Cunha Ribeiro; Renata Lúcia Pereira Vieira; Jerusa Almeida; Ana Paula Nadu; Ana Cristina Simões e Silva; Robson Augusto Souza Santos
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

Review 7.  Outcomes of transjugular intrahepatic portosystemic shunts for ascites.

Authors:  Zachary L Bercu; Aaron M Fischman
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

8.  Use of ß-blocker therapy to prevent primary bleeding of esophageal varices.

Authors:  Tammy Tursi
Journal:  J Am Acad Nurse Pract       Date:  2010-11-09

9.  Therapeutic effect of captopril, pentoxifylline, and cordyceps sinensis in pre-hepatic portal hypertensive rats.

Authors:  Ahmed F Ahmed; Nabila N El-Maraghy; Rasha H Abdel Ghaney; Shimaa M Elshazly
Journal:  Saudi J Gastroenterol       Date:  2012 May-Jun       Impact factor: 2.485

10.  Portacaval shunt established in six dogs using magnetic compression technique.

Authors:  Xiaopeng Yan; Chao Fan; Jia Ma; Jianhui Li; Dinghui Dong; Haohua Wang; Feng Ma; Xinglong Zheng; Yi Lv
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.